Trevi Therapeutics

Trevi Therapeutics

Market Cap (Mar-08-2026)
1.71 Billion USD
World Rank (Jan-05-2024)
22,095
Market Cap (Jan-05-2024)
0.088 Billion USD
World Rank (Jul-30-2023)
20,000
Market Cap (Jul-30-2023)
0.138 Billion USD
World Rank (Jan-07-2022)
21,111
World Rank (Jan-01-2021)
21,111
Market Cap (Jan-01-2021)
0.044 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TRVI
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
TREVI THERAPEUTICS
Yahoo
Yahoo @ Nasdaq
Company Profile

Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.

Founded Year
2011
IPO Year
2019
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share